Content Managers Advisory Group

Page tree

Summary

A briefing note is to solicit feedback on the proposal to inactivate role groupers in the Substance hierarchy and the Medicinal Product hierarchy. Please see the PDF for further details. 


Relevant documents

  File Modified
PDF File 20231103 BN Role Grouper Consultation.pdf 2023-Nov-06 by Cathy Richardson
PDF File 202206_Olivier Bodenreider.pdf 2023-Nov-18 by Olivier Bodenreider
PDF File Universal Summary of results of role groupers consultation final (1).pdf 2024-Mar-19 by Cathy Richardson


Actions: 

Date

Requested action

Requester(s)

Response required by:

 

Please provide feedback and comments to info@snomed.org by December 15th, 2023 31st January 2024 (marked in the heading for the attention of Nicki Ingram and Farzaneh Ashrafi).

Feedback period extended. 

Nicola Ingram 

Farzaneh Ashrafi 



  • No labels

2 Comments

  1. Olivier Bodenreider

    Therapeutic roles in SNOMED CT have been studied and compared to the MED-RT classification. See this presentation at the SNOMED Expo in 2022:

    While this investigation does not directly answer the questions posed in the briefing, it sheds some light on the potential usefulness of the therapeutic roles and offers some replacement solution for them.


  2. Nicola Ingram

    Thank you Olivier Bodenreider  and it was great to meet you and your colleague Robert Wynne in Atlanta. 

    Thank you for your presentation comparing therapeutic classes between MED-RT and SNOMED CT. Does MED-RT have international usage outside of the US?  Is there a mapping to SNOMED CT? https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/MED-RT/index.html

    We are collating all feedback from our consultation and will be creating a Briefing Note in due course for circulation to stakeholders.

    Farzaneh Ashrafi Jim Case Monica Harry Jane Millar